Indian Hume Pipe (INDIANHUME)

Cyclical

FairStock Score: 26/100 — RISKY

Score breakdown: P/E: 2/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Current Price₹369.15
Market Cap₹1,944.75 Cr
P/E Ratio13.77
ROCE11.91%
ROE71.35%
Dividend Yield0.54%
Profit Growth7.53%
Debt/Equity0.28
Sales Growth-5.16%
Promoter Holding72.34%
52-Week Range₹280 — ₹429
SectorIndustrial Manufacturing
Book Value₹281.76

Strengths

Concerns

AI Analysis

Indian Hume Pipe is not the kind of business that would earn praise from me at first glance. Sales are down 25.89% and profits are down 14.27% — hardly a growing machine. At ₹333.45, the market cap of ₹1,752 Cr gives a P/E of 16.71, which I find too generous for a shrinking business. Book value stands at ₹164.02, so the price is more than twice book; Graham would demand a margin of safety, and I don't see one here. The reported ROE of 71.35% looks spectacular, but I have learned to be suspicious of such numbers. When ROCE is just 11.91% and the Piotroski F-Score is 3/9, the high ROE likely reflects a thin equity base, not a durable competitive advantage. That is not a moat. The company does have low debt at 0.36 D/E and promoters hold 72.34%, which aligns interests. The latest quarter shows net profit of ₹62 Cr on sales of ₹282 Cr, a 22% margin; in an industrial product company, that is often a cyclical peak or an order-mix effect that cannot be projected with confidence. A strong single quarter in a declining year does not pass the Buffett test. Infrastructure-related pipe demand is cyclical, tied to government spending and order flows. The price is within its 52-week range of ₹280-429, but the dividend yield of only 0.54% gives me no comfort while waiting. With a FairStock Score of 14/100, this looks risky. I would not buy today. I would wait for either a much lower price, consistent earnings recovery, or clear evidence that revenue growth has returned before treating this as a worthwhile investment.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer